Bridging the Gaps

New Directions and Practice Impacting Recommendations in Multiple Sclerosis
Faculty presenters: Erin Longbrake, MD, PhD (Meeting Chair and Publication Editor); Stephen Krieger, MD; Carrie M. Hersh, DO, MSc, FAAN; Jens Kuhle, MD, PhD; Pascal Sati, PhD; Robert T. Naismith, MD; Fredrik Piehl, MD; Riley Bove, MD; and Ahmed Z. Obeidat, MD.
This NeurologyLive supplement comprises 3 articles that review the evolving biological understanding of multiple sclerosis (MS) and the associated implications for treatment. The publication also explores emerging biomarkers in MS as well as the latest ideas on the use of disease-modifying therapies, including scenarios for starting, switching, or stopping immunotherapy.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Grants Orexin Agonist Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1
2
Phase 1/2a Findings Lend Support for BB-301 in Oculopharyngeal Muscular Dystrophy
3
Newer Oral Levodopa Formulations in Parkinson’s Disease
4
Integrating AI and Translational Science to Advance ALS Care: Crystal Yeo, MD, PhD
5
